Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: August 2019

Workgroups: Cancer Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends that primary care clinicians conduct a risk assessment for women who are at increased risk of having mutations in specific genes that are associated with increased cancer risk. Specifically, USPSTF recommends assessing women for mutation in the BRCA1 and BRCA2 genes if they meet at least 1 of these criteria:

  • Have had breast, ovarian, tubal, or peritoneal cancer
  • Have a family history of breast, ovarian, tubal, or peritoneal cancer
  • Have ancestry that is associated with increased risk for BRCA mutation

USPSTF recommends that providers offer counseling about genetic testing to all women they assess as having an increased risk for BRCA mutations, and provide testing for those who want it after counseling.

For women who aren't at increased risk, USPSTF recommends against routine risk assessment, genetic counseling, and genetic testing.

Read more about this resource

Objectives related to this resource (1)

Suggested Citation

1.

U.S. Preventive Services Task Force. (2019). BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing.